Frank Steven 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Sep 3, 2025
Insider Transaction Report
Form 4
Frank Steven
Director
Transactions
- Award
Common Stock
2025-08-29$8.31/sh+1,353$11,243→ 16,052 total
Footnotes (1)
- [F1]Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $11,250.